Pure Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Sell |
1,072
-72
| -6% | -$29.2K | 0.01% | 319 |
|
|
2025
Q1 | $569K | Buy |
1,144
+27
| +2% | +$13.4K | 0.01% | 222 |
|
|
2024
Q4 | $581K | Buy |
1,117
+73
| +7% | +$38K | 0.01% | 203 |
|
|
2024
Q3 | $645K | Buy |
1,044
+522
| +100% | +$323K | 0.02% | 190 |
|
|
2024
Q2 | $288K | Buy |
522
+112
| +27% | +$61.9K | 0.01% | 256 |
|
|
2024
Q1 | $238K | Buy |
410
+22
| +6% | +$12.8K | 0.01% | 279 |
|
|
2023
Q4 | $206K | Sell |
388
-331
| -46% | -$176K | 0.01% | 288 |
|
|
2023
Q3 | $364K | Buy |
719
+62
| +9% | +$31.4K | 0.01% | 196 |
|
|
2023
Q2 | $343K | Sell |
657
-145
| -18% | -$75.7K | 0.01% | 195 |
|
|
2023
Q1 | $462K | Sell |
802
-2
| -0.2% | -$1.15K | 0.02% | 170 |
|
|
2022
Q4 | $443K | Buy |
804
+234
| +41% | +$129K | 0.02% | 167 |
|
|
2022
Q3 | $289K | Buy |
570
+19
| +3% | +$9.63K | 0.02% | 184 |
|
|
2022
Q2 | $299K | Buy |
551
+7
| +1% | +$3.8K | 0.02% | 187 |
|
|
2022
Q1 | $321K | Sell |
544
-2
| -0.4% | -$1.18K | 0.01% | 176 |
|
|
2021
Q4 | $364K | Sell |
546
-2
| -0.4% | -$1.33K | 0.02% | 150 |
|
|
2021
Q3 | $313K | Buy |
548
+15
| +3% | +$8.57K | 0.02% | 151 |
|
|
2021
Q2 | $269K | Hold |
533
| – | – | 0.02% | 169 |
|
|
2021
Q1 | $243K | Hold |
533
| – | – | 0.02% | 167 |
|
|
2020
Q4 | $248K | Buy |
533
+10
| +2% | +$4.65K | 0.03% | 158 |
|
|
2020
Q3 | $231K | Buy |
+523
| New | +$231K | 0.03% | 141 |
|